| Quote | Spy SMA NEW ![]() |
Message Board | |||||
|
Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders. |
|
Symmetry Medical Tops Q4 Views; Guides FY10
SMA Linked by StreetInsider - February 25, 07:19AM from (www.streetinsider.com) more ...
Symmetry Medical Reports Fourth Quarter and Full Year 2009 Financial Results
SMA Posted by PR Newswire - February 25, 07:00AM WARSAW, Ind., Feb. 25 /PRNewswire-FirstCall/ -- Symmetry more ...
Symmetry Medical upgraded to "overweight"
SMA Linked by newratings - January 06, 11:43AM from (www.newratings.com) NEW YORK, January 6 (newratings.com) - Analysts at Piper Jaffray upgrade Symmetry Medical (ticker: SMA) from "neutral" more ...
Symmetry Medical Announces Restructuring
SMA Posted by PR Newswire - December 18, 12:02PM WARSAW, Ind., Dec. 18 /PRNewswire-FirstCall/ -- Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products more ...
Analyst upgrades, downgrades and initiations: CVS, FICO, HOTT, INTC, MNTA, TXN ...
EGP INTC CVS TXN PKY BDN FICO IIVI GSIC LEA CPT MAA NBIX AVB ASML HOTT KRC BXP SLG ARMH MRVL MNTA SMA MYRX Linked by BloggingStocks - November 19, 11:30AM from (www.bloggingstocks.com) Analyst upgrades: Oppenheimer upgraded Momenta Pharmaceuticals (MNTA) to outperform from perform as it finds more ...
Symmetry Medical Misses Q3 EPS by 1c; Guides Lower
SMA Linked by StreetInsider - November 05, 08:21AM from (www.streetinsider.com) more ...
Symmetry Medical Tops Q2 EPS by 4c; Mixed Gudiance
SMA Linked by StreetInsider - August 06, 08:39AM from (www.streetinsider.com) more ...
Symmetry Medical Reports Q1 In-Line
SMA Linked by StreetInsider - May 07, 08:22AM from (www.streetinsider.com) more ...
Symmetry Medical Tops Q4 View By 5c; Guides Down
SMA Linked by StreetInsider - February 24, 08:40AM from (www.streetinsider.com) more ...
Early Bird Analyst Upgrades
ELN ATML FDP ICLR SMA SLW Linked by 24/7 Wall St. - January 13, 07:19AM from (www.247wallst.com) These are some of the top pre-market analyst upgrades from Wall Street which we have seen this Tuesday morning with more more ...
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | About | Register | My tickerspy | Logout | Web site design by LightMix |
| © 2010 Indie Research, LLC. All rights reserved. | |
---
Institutional Holdings Disclaimer Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter. Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time. tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors. THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF.
|
|